Human and veterinary drugs in the environment

Research output: Contributions to collected editions/worksArticles for encyclopediaResearch

Authors

Pharmaceutical micropollutants in the environment are seen as a threat to health, water, and food safety. Drug residues present in the environment impose adverse effects to aquatic world. Recent research has shown that this problem cannot be solved with advanced treatment processes. Very often, pharmaceuticals are transformed to other products. Effects and risk assessments are generally performed based on single compounds instead of cocktail mixture which is not the situation in the environment. The sustainable solution for pharmaceutical emerging contaminants in the environment will be benign by design, which can be the paradigm of the future. Benign by design means that easy (bio)degradability of pharmaceuticals (and/or chemicals) after use or application is taken into account even before it is synthesized, that is, during the lead optimization stages. It is an important concept within green and sustainable pharmacy and chemistry and very promising in terms of sustainability.

Original languageEnglish
Title of host publicationEncyclopedia of the Anthropocene
Number of pages6
Volume1-5
PublisherElsevier B.V.
Publication date01.01.2017
Pages263-268
ISBN (print)9780128135761
ISBN (electronic)9780128096659
DOIs
Publication statusPublished - 01.01.2017

Bibliographical note

Publisher Copyright:
© 2018 Elsevier Inc. All rights reserved.

    Research areas

  • Benign by design, Emerging contaminants, Environment fate, Legalization, Metabolite, Pharmaceutical micropollutant, Risk assessment, Sustainable chemistry, Toxicity, Transformation product, Wastewater treatment
  • Chemistry